IPOs are back in favour as Indian investors lap up Ujjivan, Thyrocare issues

Ujjivan has recently sold about 12.6 million shares to 17 domestic institutional investors at Rs210 per share. Photo: Hemant Mishra/Mint

Printed by Unregistered user on Sun, 07 Dec 2025 15:34:05 GMT